April 15, 2021
NOT-OD-22-062 - Further Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic.
NOT-GM-22-018 - Notice to Extend Eligibility for Submission of NIGMS Applications to PA-20-188, "NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)" Due to COVID related Disruptions
PA-20-187 - NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)
PA-20-188 - NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)
PA-20-189 - NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
NOT-OD-20-158 - Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
Office of The Director, National Institutes of Health (OD)
Under normal circumstances, individuals must have no more than four years of postdoctoral research experience to be eligible to apply for a K99/R00 Pathway to Independence award. The purpose of this notice is to inform the extramural community that due to disruptions caused by the COVID-19 pandemic, NIH will be extending the two-receipt cycle extension (roughly eight additional months) of eligibility for prospective, eligible candidates for a K99/R00 application. Individuals whose final due date eligibility based on a 48 month eligibility window was either the June/July 2021 or October/November 2021 will have a 2 cycle extension of eligibility (to February/March 2022 and June/July, 2022, respectively).
Individuals who have previously received the 2 cycle automatic COVID-based eligibility extension for K99 submission are not eligible for an additional extension. Furthermore, multiple extensions for events occurring during the same time period (e.g., childbirth during the COVID pandemic) will not be permitted, but rather prospective K99 candidates may only receive an extension for one category for events that occurred within overlapping time periods.
The two-receipt cycle extension in eligibility under this Notice applies only to applicants for a K99/R00 award under one of the parent Funding Opportunity Announcements (PA-20-187, PA-20-188, and PA-20-189).
For eligible applicants submitting new or resubmission applications, the two-receipt cycle extension will be automatically accepted by the NIH; no additional documentation is required.
To aid potential applicants in determining whether they are eligible for the extension, the following examples are provided:
Example 1: For individuals whose eligibility would normally end with the June/July 12, 2021 due dates, the temporary extension would allow them to apply for the K99/R00 in October/November 2021 or February/March 2022.
Example 2: For individuals whose eligibility would normally end with October/November 12, 2021 due dates, the temporary extension would allow them to apply in February/March 2022 or June/July 2022.
Example 3: For individuals whose eligibility would normally end with February/March 12, 2021 due dates, the temporary extension allowed in NOT-OD-20-158 allowed them to apply in June/July 2021 or October/November 2021. They are not eligible for an additional 2 cycle extension to February/March 2022 or June/July 2022.
This policy may be subject to future updates.
Prospective applicants should direct inquiries related to their specific circumstances to the NIH Institute or Center to which their application will be submitted.